{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:14:44Z","timestamp":1791846884408,"version":"4.3.4"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA058277"],"award-info":[{"award-number":["R01 DA058277"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>More than one million people have died from drug overdose in the United States in the past 20\u00a0years. The overdose crisis started in the late 1990s with the proliferation of overdoses involving prescription opioids, transitioned to heroin-involved overdoses in 2010, and is currently driven by illegally manufactured synthetic opioids such as fentanyl. In response to this crisis, New York City implemented two publicly recognized overdose prevention centers (OPCs) in the nation in November 2021. Rhode Island became the first US state to authorize OPCs through state legislation and will open a site in Fall 2024. We are conducting a rigorous, multi-site, multi-component evaluation of OPCs in New York City and Rhode Island. At the individual level, we assess whether a cohort of 500 persons utilizing OPCs experience lower rates of overdose, other health problems (e.g., hepatitis C, skin infections), and emergency department use, and a higher rate of substance use treatment initiation, compared to a cohort of 500 persons who use drugs but do not utilize OPCs. At the community level, we examine whether neighborhoods surrounding the OPCs experience a greater change in overdose, measures of drug-related public disorder, and acute economic conditions following the opening of OPCs, compared to neighborhoods with no OPCs. Third, we delve into the role that the operational context, including neighborhood location, program models, and operating procedures, plays in shaping the effectiveness of OPCs using qualitative and ethnographic approaches. Fourth, we estimate the costs and cost savings associated with starting up and operating OPCs. In this paper, we: (1) present the study design and harm reduction framework which is used to evaluate the impact of OPCs in New York City and Rhode Island; (2) share the types of assessment instruments and data sources used to measure changes at the individual and community level; and (3) discuss the strengths and limitations associated with the planned approach to evaluate the health and community effects of OPCs.<\/jats:p>","DOI":"10.1186\/s12954-025-01211-1","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:43:55Z","timestamp":1747111435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Study assessing the effectiveness of overdose prevention centers through evaluation research (SAFER): an overview of the study protocol"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-7046","authenticated-orcid":false,"given":"Magdalena","family":"Cerd\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Czarina N.","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Santacatterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Jent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"1211_CR1","doi-asserted-by":"crossref","unstructured":"Spencer M, Garnett M, Mini\u00f1o A. Drug overdose deaths in the United States, 2002\u20132022 [Internet]. National center for health statistics (U.S.); 2023 Dec. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/135849","DOI":"10.15620\/cdc:135849"},{"issue":"10","key":"1211_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","volume":"68","author":"K Cranston","year":"2019","unstructured":"Cranston K, Alpren C, John B, Dawson E, Roosevelt K, Burrage A, et al. Notes from the field: HIV diagnoses among persons who inject drugs\u2014Northeastern Massachusetts, 2015\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68(10):253\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1211_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015. N Engl J Med. 2016;375(3):229\u201339.","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"1211_CR4","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","volume":"222","author":"SB Lyss","year":"2020","unstructured":"Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs-United States, 2016\u20132019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Suppl 5):S239\u201349.","journal-title":"J Infect Dis"},{"issue":"15","key":"1211_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.15585\/mmwr.mm7015a1","volume":"70","author":"F Luo","year":"2021","unstructured":"Luo F, Li M, Florence C. State-level economic costs of opioid use disorder and fatal opioid overdose: United States, 2017. MMWR Morb Mortal Wkly Rep. 2021;70(15):541\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1211_CR6","unstructured":"Drug Policy Alliance [Internet]. [cited 2022 Mar 1]. Supervised consumption services. Available from: http:\/\/www.drugpolicy.org\/resource\/supervised-consumption-services"},{"key":"1211_CR7","unstructured":"Mulvaney K. The providence journal. 2021 [cited 2024 Jul 24]. RI Gov. McKee signs legislation allowing safe-injection sites into law. Available from: https:\/\/www.providencejournal.com\/story\/news\/2021\/07\/07\/gov-mckee-signs-legislation-allowing-safe-injection-sites-into-law\/7891057002\/"},{"key":"1211_CR8","unstructured":"Mays JC, Newman A. Nation\u2019s first supervised drug-injection sites open in New York. The New York Times [Internet]. 2021 Nov 30 [cited 2024 Jul 24]; Available from: https:\/\/www.nytimes.com\/2021\/11\/30\/nyregion\/supervised-injection-sites-nyc.html"},{"issue":"2","key":"1211_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11524-023-00717-y","volume":"100","author":"RE Giglio","year":"2023","unstructured":"Giglio RE, Mantha S, Harocopos A, Saha N, Reilly J, Cipriano C, et al. The nation\u2019s first publicly recognized overdose prevention centers: lessons learned in New York City. J Urban Health. 2023;100(2):245\u201354.","journal-title":"J Urban Health"},{"issue":"7","key":"1211_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22149","volume":"5","author":"A Harocopos","year":"2022","unstructured":"Harocopos A, Gibson BE, Saha N, McRae MT, See K, Rivera S, et al. First 2 months of operation at first publicly recognized overdose prevention centers in US. JAMA Netw Open. 2022;5(7): e2222149.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1211_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14(5):161\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"11","key":"1211_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002964","volume":"16","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Hayashi K, Milloy MJ, Wood E, Kerr T. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: a cohort study. PLoS Med. 2019;16(11): e1002964.","journal-title":"PLoS Med"},{"issue":"5","key":"1211_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised injection facilities as harm reduction: a systematic review. Am J Prev Med. 2021;61(5):738\u201349.","journal-title":"Am J Prev Med"},{"issue":"145","key":"1211_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"1","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;1(145):48\u201368.","journal-title":"Drug Alcohol Depend"},{"key":"1211_CR15","doi-asserted-by":"crossref","unstructured":"Pardo B, Caulkins J, Kilmer B. Assessing the evidence on supervised drug consumption sites. RAND Corporation (2018).","DOI":"10.7249\/WR1261"},{"key":"1211_CR16","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Drug consumption rooms: an overview of provision and evidence (perspectives on drugs) [Internet]. Lisbon: EMCDDA; 2018 [cited 2024 Jul 24]. Available from: https:\/\/www.emcdda.europa.eu\/publications\/pods\/drug-consumption-rooms_en"},{"issue":"9775","key":"1211_CR17","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BDL Marshall","year":"2011","unstructured":"Marshall BDL, Milloy MJ, Wood E, Montaner JSG, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429\u201337.","journal-title":"Lancet"},{"issue":"2","key":"1211_CR18","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/S2468-2667(23)00300-6","volume":"9","author":"I Rammohan","year":"2024","unstructured":"Rammohan I, Gaines T, Scheim A, Bayoumi A, Werb D. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis. Lancet Public Health. 2024;9(2):e79-87.","journal-title":"Lancet Public Health"},{"issue":"4","key":"1211_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","volume":"105","author":"AM Salmon","year":"2010","unstructured":"Salmon AM, van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia: Impact of a SIF on ambulance utilization. Addiction. 2010;105(4):676\u201383.","journal-title":"Addiction"},{"issue":"6","key":"1211_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/09595230801995668","volume":"27","author":"J Kimber","year":"2008","unstructured":"Kimber J, Mattick RP, Kaldor J, van Beek I, Gilmour S, Rance JA. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev. 2008;27(6):602\u201312.","journal-title":"Drug Alcohol Rev"},{"issue":"23","key":"1211_CR21","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1056\/NEJMc052939","volume":"354","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Zhang R, Stoltz JA, Lai C, Montaner JSG, et al. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006;354(23):2512\u20134.","journal-title":"N Engl J Med"},{"issue":"2\u20133","key":"1211_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2010.07.023","volume":"113","author":"K DeBeck","year":"2011","unstructured":"DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, et al. Injection drug use cessation and use of North America\u2019s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2\u20133):172\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1211_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/ije\/dyac120","volume":"52","author":"P Roux","year":"2023","unstructured":"Roux P, Jauffret-Roustide M, Donadille C, Briand Madrid L, Denis C, C\u00e9l\u00e9rier I, et al. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort. Int J Epidemiol. 2023;52(2):562\u201376.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1211_CR24","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1186\/s12889-024-18909-9","volume":"24","author":"A Cousien","year":"2024","unstructured":"Cousien A, Donadille C, Madrid LB, Maradan G, Jauffret-Roustide M, Lalanne L, et al. Cost-effectiveness of drug consumption rooms in France: a modelling study. BMC Public Health. 2024;24(1):1426.","journal-title":"BMC Public Health"},{"issue":"2","key":"1211_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/QAI.0000000000002849","volume":"89","author":"LW Suen","year":"2022","unstructured":"Suen LW, Davidson PJ, Browne EN, Lambdin BH, Wenger LD, Kral AH. Effect of an unsanctioned safe consumption site in the United States on syringe sharing, rushed injections, and isolated injection drug use: a longitudinal cohort analysis: a longitudinal cohort analysis. J Acquir Immune Defic Syndr. 2022;89(2):172\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"15","key":"1211_CR26","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1007\/s11606-021-07312-4","volume":"37","author":"BH Lambdin","year":"2022","unstructured":"Lambdin BH, Davidson PJ, Browne EN, Suen LW, Wenger LD, Kral AH. Reduced emergency department visits and hospitalisation with use of an unsanctioned safe consumption site for injection drug use in the United States. J Gen Intern Med. 2022;37(15):3853\u201360.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"1211_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25538","volume":"4","author":"A Macmadu","year":"2021","unstructured":"Macmadu A, Batthala S, Correia Gabel AM, Rosenberg M, Ganguly R, Yedinak JL, et al. Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island. JAMA Netw Open. 2021;4(9): e2125538.","journal-title":"JAMA Netw Open"},{"issue":"103554","key":"1211_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103554","volume":"101","author":"AS Bennett","year":"2022","unstructured":"Bennett AS, Townsend T, Elliott L. The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months. Int J Drug Policy. 2022;101(103554): 103554.","journal-title":"Int J Drug Policy"},{"key":"1211_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugpo.2017.12.005","volume":"53","author":"PJ Davidson","year":"2018","unstructured":"Davidson PJ, Lopez AM, Kral AH. Using drugs in un\/safe spaces: impact of perceived illegality on an underground supervised injecting facility in the United States. Int J Drug Policy. 2018;53:37\u201344.","journal-title":"Int J Drug Policy"},{"issue":"31","key":"1211_CR30","doi-asserted-by":"publisher","first-page":"E921","DOI":"10.1503\/cmaj.180824","volume":"190","author":"A Scheim","year":"2018","unstructured":"Scheim A, Werb D. Integrating supervised consumption into a continuum of care for people who use drugs. CMAJ. 2018;190(31):E921\u20132.","journal-title":"CMAJ"},{"issue":"5","key":"1211_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jval.2024.02.004","volume":"27","author":"CN Behrends","year":"2024","unstructured":"Behrends CN, Leff JA, Lowry W, Li JM, Onuoha EN, Fardone E, et al. Economic evaluations of establishing opioid overdose prevention centers in 12 north American cities: a systematic review. Value Health. 2024;27(5):655\u201369.","journal-title":"Value Health"},{"key":"1211_CR32","unstructured":"Rhode Island Department of Health. Harm reduction centers [Internet]. [cited 2024 Jul 24]. Available from: https:\/\/health.ri.gov\/addiction\/about\/harmreductioncenters\/"},{"issue":"112384","key":"1211_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112384","volume":"234","author":"AB Collins","year":"2019","unstructured":"Collins AB, Boyd J, Cooper HLF, McNeil R. The intersectional risk environment of people who use drugs. Soc Sci Med. 2019;234(112384): 112384.","journal-title":"Soc Sci Med"},{"key":"1211_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","volume":"105","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W, Wood E, Kerr T. Hospitals as a \u201crisk environment\u201d: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014;105:59\u201366.","journal-title":"Soc Sci Med"},{"issue":"102840","key":"1211_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102840","volume":"83","author":"H Reddon","year":"2020","unstructured":"Reddon H, Kerr T, Milloy MJ. Ranking evidence in substance use and addiction. Int J Drug Policy. 2020;83(102840): 102840.","journal-title":"Int J Drug Policy"},{"key":"1211_CR36","first-page":"656","volume-title":"Experimental and quasi-experimental designs for generalized causal inference","author":"DT Campbell","year":"2001","unstructured":"Campbell DT, Cook TD, Shadish WR Jr. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton Mifflin; 2001. p. 656."},{"key":"1211_CR37","unstructured":"Drug Policy Alliance [Internet]. [cited 2022 Mar 1]. Safe consumption site data harmonization convening. Available from: https:\/\/drugpolicy.org\/event\/safe-consumption-site-data-harmonization-convening"},{"key":"1211_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","volume":"68","author":"A Macmadu","year":"2017","unstructured":"Macmadu A, Carroll JJ, Hadland SE, Green TC, Marshall BDL. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35\u20138.","journal-title":"Addict Behav"},{"issue":"1","key":"1211_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12954-017-0139-0","volume":"14","author":"BA Bouvier","year":"2017","unstructured":"Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BDL. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017;14(1):13.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1211_CR40","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1186\/s13063-020-04898-8","volume":"21","author":"BP Jacka","year":"2020","unstructured":"Jacka BP, Goldman JE, Yedinak JL, Bernstein E, Hadland SE, Buxton JA, et al. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial. Trials. 2020;21(1):976.","journal-title":"Trials"},{"issue":"4","key":"1211_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/add.15717","volume":"117","author":"MC Kennedy","year":"2022","unstructured":"Kennedy MC, Hayashi K, Milloy MJ, Compton M, Kerr T. Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis. Addiction. 2022;117(4):986\u201397.","journal-title":"Addiction"},{"key":"1211_CR42","unstructured":"National Center for Health Statistics (office of analysis and epidemiology). The linkage of national center for health statistics survey data to medicaid enrollment and claims data: methodology and analytic considerations. (2019)."},{"issue":"11","key":"1211_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032052","volume":"9","author":"WC Goedel","year":"2019","unstructured":"Goedel WC, Marshall BDL, Samuels EA, Brinkman MG, Dettor D, Langdon KJ, et al. Randomised clinical trial of an emergency department-based peer recovery support intervention to increase treatment uptake and reduce recurrent overdose among individuals at high risk for opioid overdose: study protocol for the navigator trial. BMJ Open. 2019;9(11): e032052.","journal-title":"BMJ Open"},{"key":"1211_CR44","first-page":"700","volume-title":"Survival analysis: a self-learning text, third edition","author":"DG Kleinbaum","year":"2011","unstructured":"Kleinbaum DG, Klein M. Survival analysis: a self-learning text, third edition. 3rd ed. New York: Springer; 2011. p. 700.","edition":"3"},{"issue":"5","key":"1211_CR45","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","volume":"11","author":"MA Hern\u00e1n","year":"2000","unstructured":"Hern\u00e1n MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5):561\u201370.","journal-title":"Epidemiology"},{"issue":"3","key":"1211_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1009672031531","volume":"5","author":"P Hougaard","year":"1999","unstructured":"Hougaard P. Multi-state models: a review. Lifetime Data Anal. 1999;5(3):239\u201364.","journal-title":"Lifetime Data Anal"},{"key":"1211_CR47","unstructured":"Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data [Internet]. 2nd ed. Newy York: Wiley-Interscience; 2011. 462 p. (Wiley Series in Probability and Statistics). Available from: https:\/\/play.google.com\/store\/books\/details?id=BR4Kq-a1MIMC"},{"issue":"10","key":"1211_CR48","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/sim.8080","volume":"38","author":"M Santacatterina","year":"2019","unstructured":"Santacatterina M, Garc\u00eda-Pareja C, Bellocco R, S\u00f6nnerborg A, Ekstr\u00f6m AM, Bottai M. Optimal probability weights for estimating causal effects of time-varying treatments with marginal structural Cox models: optimal probability weights for MSCM. Stat Med. 2019;38(10):1891\u2013902.","journal-title":"Stat Med"},{"key":"1211_CR49","unstructured":"Kallus N, Santacatterina M. Optimal balancing of time-dependent confounders for marginal structural models [Internet]. arXiv [stat.ME]. 2018. Available from: http:\/\/arxiv.org\/abs\/1806.01083"},{"issue":"6","key":"1211_CR50","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/ije\/dyaa156","volume":"49","author":"A Breskin","year":"2021","unstructured":"Breskin A, Edmonds A, Cole SR, Westreich D, Cocohoba J, Cohen MH, et al. G-computation for policy-relevant effects of interventions on time-to-event outcomes. Int J Epidemiol. 2021;49(6):2021\u20139.","journal-title":"Int J Epidemiol"},{"key":"1211_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.socscimed.2017.12.026","volume":"203","author":"J Merlo","year":"2018","unstructured":"Merlo J. Multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework. Soc Sci Med. 2018;203:74\u201380.","journal-title":"Soc Sci Med"},{"issue":"101032","key":"1211_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2022.101032","volume":"17","author":"M Mahendran","year":"2022","unstructured":"Mahendran M, Lizotte D, Bauer GR. Quantitative methods for descriptive intersectional analysis with binary health outcomes. SSM Popul Health. 2022;17(101032): 101032.","journal-title":"SSM Popul Health"},{"key":"1211_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsat.2019.08.010","volume":"106","author":"CN Behrends","year":"2019","unstructured":"Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, et al. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. J Subst Abuse Treat. 2019;106:79\u201388.","journal-title":"J Subst Abuse Treat"},{"issue":"1\u20132","key":"1211_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drugalcdep.2010.02.009","volume":"110","author":"AH Kral","year":"2010","unstructured":"Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010;110(1\u20132):160\u20133.","journal-title":"Drug Alcohol Depend"},{"key":"1211_CR55","unstructured":"Fisher B, Allard C. Feasibility study on \u201csupervised drug consumption\u201d options in the City of Victoria. Centre for addictions research of British Columbia (CARBC), University of Victoria (2007)."},{"key":"1211_CR56","unstructured":"Bayoumi AM, Strike C, Brandeau M, Degani N, Fischer B, Glazier R, et al. Report of the Toronto and Ottawa supervised consumption assessment study [Internet]. [cited 2024 Oct 25]. Available from: https:\/\/research.unityhealth.to\/research-programs\/urban-health-solutions\/resources-and-reports\/report-of-the-toronto-and-ottawa-supervised-consumption-assessment-study\/"},{"key":"1211_CR57","unstructured":"US Census Bureau. Glossary. 2022 Apr 12 [cited 2024 Oct 14]; Available from: https:\/\/www.census.gov\/programs-surveys\/geography\/about\/glossary.html"},{"issue":"6","key":"1211_CR58","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.socscimed.2008.12.048","volume":"68","author":"SE Spielman","year":"2009","unstructured":"Spielman SE, Yoo EH. The spatial dimensions of neighborhood effects. Soc Sci Med. 2009;68(6):1098\u2013105.","journal-title":"Soc Sci Med"},{"issue":"10","key":"1211_CR59","first-page":"62","volume":"103","author":"BD Hallowell","year":"2020","unstructured":"Hallowell BD, Weidele HR, Scagos RP. Accidental drug overdose deaths in Rhode Island: January 1, 2016-July 31, 2020. RI Med J. 2020;103(10):62\u20135.","journal-title":"RI Med J"},{"issue":"2","key":"1211_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.15585\/mmwr.mm6802a3","volume":"68","author":"C Colon-Berezin","year":"2019","unstructured":"Colon-Berezin C, Nolan ML, Blachman-Forshay J, Paone D. Overdose deaths involving fentanyl and fentanyl analogs: New York City, 2000\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68(2):37\u201340.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1211_CR61","unstructured":"Snethen T. Death certification [Internet]. [cited 2024 Jul 24]. Available from: https:\/\/www.thename.org\/death-certification"},{"issue":"6","key":"1211_CR62","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths: United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"109271","key":"1211_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109271","volume":"232","author":"A Khare","year":"2022","unstructured":"Khare A, Sidana A, Mohemmed A, Allicock DM, Waterstone A, Zimmer MA, et al. Acceleration of opioid-related EMS runs in the spring of 2020: the national emergency medical services information system data for 2018\u20132020. Drug Alcohol Depend. 2022;232(109271): 109271.","journal-title":"Drug Alcohol Depend"},{"issue":"108521","key":"1211_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108521","volume":"220","author":"PJ Davidson","year":"2021","unstructured":"Davidson PJ, Lambdin BH, Browne EN, Wenger LD, Kral AH. Impact of an unsanctioned safe consumption site on criminal activity, 2010\u20132019. Drug Alcohol Depend. 2021;220(108521): 108521.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1211_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/09595230500167460","volume":"24","author":"K Freeman","year":"2005","unstructured":"Freeman K, Jones CGA, Weatherburn DJ, Rutter S, Spooner CJ, Donnelly N. The impact of the Sydney medically supervised injecting centre (MSIC) on crime. Drug Alcohol Rev. 2005;24(2):173\u201384.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"1211_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1747-597X-1-13","volume":"8","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Lai C, Montaner JSG, Kerr T. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy. 2006;8(1):13.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"1211_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0022042617727513","volume":"48","author":"AJ Myer","year":"2018","unstructured":"Myer AJ, Belisle L. Highs and lows: an interrupted time-series evaluation of the impact of North America\u2019s only supervised injection facility on crime. J Drug Issues. 2018;48(1):36\u201349.","journal-title":"J Drug Issues"},{"key":"1211_CR68","unstructured":"City of Providence. Providence police case log - past 180 days [Internet]. 2015 [cited 2024 Jul 24]. Available from: https:\/\/data.providenceri.gov\/Public-Safety\/Providence-Police-Case-Log-Past-180-days\/rz3y-pz8v"},{"key":"1211_CR69","unstructured":"Police Department (NYPD). NYPD arrest data (Year to Date) [Internet]. 2018 [cited 2024 Jul 24]. Available from: https:\/\/data.cityofnewyork.us\/Public-Safety\/NYPD-Arrest-Data-Year-to-Date-\/uip8-fykc"},{"key":"1211_CR70","unstructured":"City of Providence [Internet]. 2016 [cited 2024 Jul 24]. Tax Assessor. Available from: https:\/\/www.providenceri.gov\/tax-assessor\/"},{"key":"1211_CR71","unstructured":"Data and Lot Information [Internet]. [cited 2024 Jul 24]. Available from: https:\/\/www1.nyc.gov\/site\/finance\/taxes\/property-data-and-lot-information.page"},{"issue":"1","key":"1211_CR72","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1198\/000313002753631330","volume":"56","author":"LA Stefanski","year":"2002","unstructured":"Stefanski LA, Boos DD. The calculus of M-estimation. Am Stat. 2002;56(1):29\u201338.","journal-title":"Am Stat"},{"issue":"22","key":"1211_CR73","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2014.16153","volume":"312","author":"JB Dimick","year":"2014","unstructured":"Dimick JB, Ryan AM. methods for evaluating changes in health care policy: the difference-in-differences approach. JAMA. 2014;312(22):2401.","journal-title":"JAMA"},{"issue":"6","key":"1211_CR74","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2018.21554","volume":"321","author":"S Haneuse","year":"2019","unstructured":"Haneuse S, VanderWeele TJ, Arterburn D. Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321(6):602\u20133.","journal-title":"JAMA"},{"issue":"1","key":"1211_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/jci-2020-0033","volume":"9","author":"N Kallus","year":"2021","unstructured":"Kallus N, Santacatterina M. Optimal balancing of time-dependent confounders for marginal structural models. J Causal Inference. 2021;9(1):345\u201369.","journal-title":"J Causal Inference"},{"issue":"1","key":"1211_CR76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1162\/REST_a_00049","volume":"93","author":"TG Conley","year":"2011","unstructured":"Conley TG, Taber CR. Inference with \u201cdifference in differences\u201d with a small number of policy changes. Rev Econ Stat. 2011;93(1):113\u201325.","journal-title":"Rev Econ Stat"},{"issue":"1","key":"1211_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MLR.0000000000000830","volume":"56","author":"S Rokicki","year":"2018","unstructured":"Rokicki S, Cohen J, Fink G, Salomon JA, Landrum MB. Inference with difference-in-differences with a small number of groups: a review, simulation study, and empirical application using SHARE data. Med Care. 2018;56(1):97\u2013105.","journal-title":"Med Care"},{"issue":"3","key":"1211_CR78","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1207\/s15430421tip3903_2","volume":"39","author":"JW Creswell","year":"2000","unstructured":"Creswell JW, Miller DL. Determining validity in qualitative inquiry. Theory Pract. 2000;39(3):124\u201330.","journal-title":"Theory Pract"},{"issue":"2","key":"1211_CR79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/bmjqs-2013-002335","volume":"23","author":"M Leslie","year":"2014","unstructured":"Leslie M, Paradis E, Gropper MA, Reeves S, Kitto S. Applying ethnography to the study of context in healthcare quality and safety. BMJ Qual Saf. 2014;23(2):99\u2013105.","journal-title":"BMJ Qual Saf"},{"key":"1211_CR80","doi-asserted-by":"crossref","unstructured":"Hammersley M, Atkinson P. Ethnography: principles in practice [Internet]. 4th ed. London, England: Routledge; 2019. 280 p. Available from: https:\/\/play.google.com\/store\/books\/details?id=lwWSDwAAQBAJ","DOI":"10.4324\/9781315146027"},{"issue":"102845","key":"1211_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102845","volume":"87","author":"A Betsos","year":"2021","unstructured":"Betsos A, Valleriani J, Boyd J, Bardwell G, Kerr T, McNeil R. I couldn\u2019t live with killing one of my friends or anybody: a rapid ethnographic study of drug sellers\u2019 use of drug checking. Int J Drug Policy. 2021;87(102845): 102845.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1211_CR82","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s10461-016-1470-2","volume":"21","author":"R McNeil","year":"2017","unstructured":"McNeil R, Kerr T, Coleman B, Maher L, Milloy MJ, Small W. Antiretroviral therapy interruption among HIV postive people who use drugs in a setting with a community-wide HIV treatment-as-prevention initiative. AIDS Behav. 2017;21(2):402\u20139.","journal-title":"AIDS Behav"},{"issue":"13","key":"1211_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12981-016-0108-9","volume":"25","author":"W Small","year":"2016","unstructured":"Small W, Milloy MJ, McNeil R, Maher L, Kerr T. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study. AIDS Res Ther. 2016;25(13):26.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"1211_CR84","doi-asserted-by":"publisher","first-page":"21407","DOI":"10.7448\/IAS.20.1.21407","volume":"20","author":"AB Collins","year":"2017","unstructured":"Collins AB, Parashar S, Hogg RS, Fernando S, Worthington C, McDougall P, et al. Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada. J Int AIDS Soc. 2017;20(1):21407.","journal-title":"J Int AIDS Soc"},{"key":"1211_CR85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.healthplace.2015.07.006","volume":"35","author":"R McNeil","year":"2015","unstructured":"McNeil R, Cooper H, Small W, Kerr T. Area restrictions, risk, harm, and health care access among people who use drugs in Vancouver, Canada: a spatially oriented qualitative study. Health Place. 2015;35:70\u20138.","journal-title":"Health Place"},{"issue":"12","key":"1211_CR86","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/add.14417","volume":"113","author":"J Boyd","year":"2018","unstructured":"Boyd J, Collins AB, Mayer S, Maher L, Kerr T, McNeil R. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada. Addiction. 2018;113(12):2261\u201370.","journal-title":"Addiction"},{"issue":"10","key":"1211_CR87","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1080\/13691058.2020.1785550","volume":"23","author":"J Lavalley","year":"2021","unstructured":"Lavalley J, Collins AB, Mayer S, Gaudette L, Kr\u00fcsi A, McNeil R, et al. Negotiating sex work and client interactions in the context of a fentanyl-related overdose epidemic. Cult Health Sex. 2021;23(10):1390\u2013405.","journal-title":"Cult Health Sex"},{"issue":"4","key":"1211_CR88","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1475-6773.2006.00684.x","volume":"42","author":"EH Bradley","year":"2007","unstructured":"Bradley EH, Curry LA, Devers KJ. Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Serv Res. 2007;42(4):1758\u201372.","journal-title":"Health Serv Res"},{"key":"1211_CR89","unstructured":"Charmaz K. Constructing grounded theory [Internet]. 2nd ed. London, England: SAGE publications; 2014. 416 p. (introducing qualitative methods series). Available from: https:\/\/play.google.com\/store\/books\/details?id=v_GGAwAAQBAJ"},{"issue":"7 Suppl 1","key":"1211_CR90","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1097\/MLR.0b013e31819bc064","volume":"47","author":"KD Frick","year":"2009","unstructured":"Frick KD. Microcosting quantity data collection methods. Med Care. 2009;47(7 Suppl 1):S76-81.","journal-title":"Med Care"},{"key":"1211_CR91","first-page":"461","volume-title":"Methods for the economic evaluation of health care programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. London: Oxford University Press; 2015. p. 461."},{"key":"1211_CR92","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"PJ Neumann","year":"2016","unstructured":"Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine. London: Oxford University Press; 2016. p. 496."},{"key":"1211_CR93","doi-asserted-by":"crossref","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials [Internet]. OUP Oxford; 2014. 265 p. Available from: https:\/\/play.google.com\/store\/books\/details?id=Xqi1BAAAQBAJ","DOI":"10.1093\/med\/9780199685028.001.0001"},{"key":"1211_CR94","unstructured":"French MT. Drug abuse treatment cost analysis program (DATCAP). Program version. 2003;7."},{"key":"1211_CR95","unstructured":"National Institute on Drug Abuse. National institute on drug abuse. 2017 [cited 2024 Jul 24]. Seek, test, treat and retain. Available from: https:\/\/nida.nih.gov\/research\/research-data-measures-resources\/data-harmonization-projects\/seek-test-treat-retain"},{"issue":"9","key":"1211_CR96","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/j.1360-0443.2010.03001.x","volume":"105","author":"D Polsky","year":"2010","unstructured":"Polsky D, Glick HA, Yang J, Subramaniam GA, Poole SA, Woody GE. Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial: Buprenorphine cost-effectiveness in youth. Addiction. 2010;105(9):1616\u201324.","journal-title":"Addiction"},{"issue":"161","key":"1211_CR97","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.drugalcdep.2016.01.021","volume":"1","author":"SM Murphy","year":"2016","unstructured":"Murphy SM, Campbell ANC, Ghitza UE, Kyle TL, Bailey GL, Nunes EV, et al. Cost-effectiveness of an internet-delivered treatment for substance abuse: data from a multisite randomized controlled trial. Drug Alcohol Depend. 2016;1(161):119\u201326.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1211_CR98","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0272989X18776637","volume":"38","author":"B Dewitt","year":"2018","unstructured":"Dewitt B, Feeny D, Fischhoff B, Cella D, Hays RD, Hess R, et al. Estimation of a preference-based summary score for the patient-reported outcomes measurement information system: the PROMIS\u00ae-preference (PROPr) scoring system. Med Decis Making. 2018;38(6):683\u201398.","journal-title":"Med Decis Making"},{"issue":"1","key":"1211_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40352-018-0073-6","volume":"6","author":"KE McCollister","year":"2018","unstructured":"McCollister KE, Yang X, Murphy SM, Leff JA, Kronmal RA, Crane HM, et al. Criminal justice measures for economic data harmonization in substance use disorder research. Health Justice. 2018;6(1):17.","journal-title":"Health Justice"},{"key":"1211_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsat.2017.07.008","volume":"81","author":"K McCollister","year":"2017","unstructured":"McCollister K, Yang X, Sayed B, French MT, Leff JA, Schackman BR. Monetary conversion factors for economic evaluations of substance use disorders. J Subst Abuse Treat. 2017;81:25\u201334.","journal-title":"J Subst Abuse Treat"},{"key":"1211_CR101","unstructured":"Agency for healthcare research, quality. Medical expenditure panel survey home [Internet]. [cited 2024 Jul 24]. Available from: https:\/\/meps.ahrq.gov\/mepsweb\/"},{"key":"1211_CR102","unstructured":"License for use of current procedural terminology, fourth edition (\u201cCPT\u201d) [Internet]. [cited 2022 Mar 1]. Available from: https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/license-agreement?destination=\/medicare\/physician-fee-schedule\/search%3F"},{"key":"1211_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ypmed.2018.02.026","volume":"111","author":"EE McGinty","year":"2018","unstructured":"McGinty EE, Barry CL, Stone EM, Niederdeppe J, Kennedy-Hendricks A, Linden S, et al. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73\u20137.","journal-title":"Prev Med"},{"issue":"8","key":"1211_CR104","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jama.2019.0095","volume":"321","author":"LO Gostin","year":"2019","unstructured":"Gostin LO, Hodge JG Jr, Gulinson CL. Supervised injection facilities: Legal and policy reforms: legal and policy reforms. JAMA. 2019;321(8):745\u20136.","journal-title":"JAMA"},{"issue":"1","key":"1211_CR105","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1056\/NEJMp1913448","volume":"382","author":"S Burris","year":"2020","unstructured":"Burris S, Anderson ED, Davis CS, Beletsky L. Toward healthy drug policy in the United States: the case of safehouse. N Engl J Med. 2020;382(1):4\u20135.","journal-title":"N Engl J Med"},{"issue":"106070","key":"1211_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106070","volume":"135","author":"YT Yang","year":"2020","unstructured":"Yang YT, Beletsky L. United States vs Safehouse: the implications of the Philadelphia supervised consumption facility ruling for law and social stigma. Prev Med. 2020;135(106070): 106070.","journal-title":"Prev Med"},{"issue":"4","key":"1211_CR107","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1176\/appi.ps.201800398","volume":"70","author":"A Kennedy-Hendricks","year":"2019","unstructured":"Kennedy-Hendricks A, Bluestein J, Kral AH, Barry CL, Sherman SG. Establishing sanctioned safe consumption sites in the United States: five jurisdictions moving the policy agenda forward. Psychiatr Serv. 2019;70(4):294\u2013301.","journal-title":"Psychiatr Serv"},{"key":"1211_CR108","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.jsat.2021.108397","volume":"131","author":"J Taylor","year":"2021","unstructured":"Taylor J, Ober AJ, Kilmer B, Caulkins JP, Iguchi MY. Community perspectives on supervised consumption sites: insights from four US counties deeply affected by opioids. J Subst Abuse Treat. 2021;131:108397.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"1211_CR109","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/dar.12919","volume":"38","author":"V Belackova","year":"2019","unstructured":"Belackova V, Salmon AM, Day CA, Ritter A, Shanahan M, Hedrich D, et al. Drug consumption rooms: a systematic review of evaluation methodologies. Drug Alcohol Rev. 2019;38(4):406\u201322.","journal-title":"Drug Alcohol Rev"}],"updated-by":[{"DOI":"10.1186\/s12954-025-01258-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000}}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01211-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:02:16Z","timestamp":1786730536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01211-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":109,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01211-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12954-025-01258-0","URL":"https:\/\/doi.org\/10.1186\/s12954-025-01258-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the NYU Langone Health Institutional Review Board (study # i22-00114).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Cerd\u00e1 has served as an expert witness in opioid litigation.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"76"}}